COPENHAGEN, March 26 (Reuters) - Novo Nordisk
said on Thursday it would nominate Poul Weihrauch, CEO of
chocolate maker Mars, as observer to its board, as the drugmaker
tries to regain a stronger footing in the competitive U.S.
obesity market.